I agree that this site is using cookies. You can find further informations here.
X
Zhang, Zhong-Yin
1543  results:
OpenAccess-fulltext X
Search for persons X
?
1

Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Gr..:

Nguele Meke, Frederick ; Bai, Yunpeng ; Ruiz-Avila, Diego...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10764713/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
2

IUSM-Purdue TREAT-AD Center Target Enabling Component PTPN6..:

Qu, Zihan ; Dong, Jiajun ; Jassim, Brenson.
doi:10.5281/zenodo.8367640.  , 2023
Link: https://zenodo.org/recor..
 
?
3

Inhibition of PRMT5 by market drugs as a novel cancer thera..:

Prabhu, Lakshmi ; Martin, Matthew ; Chen, Lan...
10.1016/j.gendis.2022.04.001.  , 2023
Link: https://hdl.handle.net/1..
 
?
4

IUSM-Purdue TREAT-AD Center Target Enabling Component PTPN6..:

Qu, Zihan ; Dong, Jiajun ; Zhang, Zhong-Yin
doi:10.5281/zenodo.8367741.  , 2023
Link: https://zenodo.org/recor..
 
?
5

IUSM-Purdue TREAT-AD Center Target Enabling Component PTPN6..:

Qu, Zihan ; Dong, Jiajun ; Zhang, Zhong-Yin
doi:10.5281/zenodo.8367741.  , 2023
Link: https://zenodo.org/recor..
 
?
6

PRL2 phosphatase enhances oncogenic FLT3 signaling via deph..:

Chen, Hongxia ; Bai, Yunpeng ; Kobayashi, Michihiro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936309/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

IUSM-Purdue TREAT-AD Center Target Enabling Component PTPN6..:

Qu, Zihan ; Dong, Jiajun ; Jassim, Brenson.
doi:10.5281/zenodo.8367640.  , 2023
Link: https://zenodo.org/recor..
 
?
8

Establishment and characterization of patient-derived xenog..:

Damayanti, Nur P ; Saadatzadeh, M. Reza ; Dobrota, Erika...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244396/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

PRL2 inhibition elevates PTEN protein and ameliorates progr..:

Carlock, Colin ; Bai, Yunpeng ; Paige-Hood, Allison...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619439/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Establishment and characterization of patient-derived xenog..:

Damayanti, Nur P ; Saadatzadeh, M. Reza ; Dobrota, Erika...
10.1038/s41598-023-36107-2.  , 2023
Link: https://hdl.handle.net/1..
 
?
11

Tumor Cell–Autonomous SHP2 Contributes to Immune Suppressio..:

Chen, Hao ; Cresswell, Gregory M ; Libring, Sarah...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035406/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

IUSM-Purdue TREAT-AD Center Target Enabling Package; INPP5D..:

Palkowitz, Alan ; Lamb, Bruce ; Mesecar, Andrew...
doi:10.5281/zenodo.6561366.  , 2022
Link: https://zenodo.org/recor..
 
?
13

IUSM-Purdue TREAT-AD Center Target Enabling Component PLCγ2..:

Utsuki, Tadanobu ; Visvanathan, Ramya ; Beck, Daniel...
doi:10.5281/zenodo.6568020.  , 2022
Link: https://zenodo.org/recor..
 
?
14

Exploration of beta-arrestin isoform signaling pathways in ..:

Blaine, Arryn T ; Miao, Yiming ; Yuan, Jinling...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428791/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

An Integrated Proteomic Strategy to Identify SHP2 Substrate:

Zhu, Peipei ; Wu, Xiaofeng ; Zhang, Ruo-Yu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597472/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15